Walleye Trading LLC Sc Pharmaceuticals Inc. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$4.7 - $6.63 $89,652 - $126,467	19,075 Added 140.95%	32,608 $204,000
Q3 2023 Nov 14, 2023	SELL	$7.0 - $9.82 $130,417 - $182,956	-18,631 Reduced 57.93%	13,533 $96,000
Q2 2023 Aug 14, 2023	BUY	$8.94 - $11.74 $287,546 - $377,605	32,164 New	32,164 $327,000
Q3 2020 Nov 16, 2020	SELL	$7.12 - $8.86 $74,218 - $92,356	-10,424 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $73,072 - $114,247	10,424 New	10,424 $77,000

37.1M

110K

12.1K

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $91.8M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.